We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
(-5.9%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$25.4M |
| 2 |
AbbVie
ABBV
|
+$21.9M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$19.2M |
| 4 |
Waste Management
WM
|
+$19M |
| 5 |
Gilead Sciences
GILD
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70.2M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$45.8M |
| 3 |
Biogen
BIIB
|
+$43.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.8M |
| 5 |
Amgen
AMGN
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.81% |
| 2 | Technology | 18.27% |
| 3 | Financials | 10.05% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
326
Fiserv Inc
FISV
$27.9B
| $4.53M | 0.06% |
43,769
+13,647
| +45% | +$1.39M |
|
327
Micron Technology
MU
$1.02T
| $4.48M | 0.06% |
104,598
-71,607
| -41% | -$3.24M |
|
328
PPG Industries
PPG
$26.4B
| $4.48M | 0.06% |
37,784
+11,968
| +46% | +$1.38M |
|
329
T. Rowe Price
TROW
$25.5B
| $4.45M | 0.06% |
38,970
+13,873
| +55% | +$1.54M |
|
|
CLVS
330
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.45M | 0.06% |
1,131,123
+23,000
| +2% | +$186K |
|
331
Intercontinental Exchange
ICE
$84.1B
| $4.41M | 0.06% |
47,783
+3,643
| +8% | +$333K |
|
|
WRK
332
DELISTED
WestRock Company
WRK
| $4.4M | 0.06% |
120,645
-117
| -0.1% | -$4.18K |
|
333
FedEx
FDX
$73.5B
| $4.36M | 0.06% |
29,955
-553
| -2% | -$89.2K |
|
334
Qorvo
QRVO
$7.92B
| $4.36M | 0.06% |
58,800
-31,584
| -35% | -$2.29M |
|
335
Boston Scientific
BSX
$67.6B
| $4.36M | 0.06% |
107,017
+2,775
| +3% | +$118K |
|
|
ETFC
336
DELISTED
E*Trade Financial Corporation
ETFC
| $4.35M | 0.06% |
99,559
-42,482
| -30% | -$1.88M |
|
337
Norfolk Southern
NSC
$77.1B
| $4.34M | 0.06% |
24,135
+1,611
| +7% | +$296K |
|
|
BNY
338
Bank of New York Mellon
BNY
$107B
| $4.3M | 0.06% |
95,210
-557
| -0.6% | -$24.8K |
|
339
JD.com
JD
$41.8B
| $4.3M | 0.06% |
152,287
+75,137
| +97% | +$2.27M |
|
340
Deere & Co
DE
$169B
| $4.28M | 0.06% |
25,369
+1,220
| +5% | +$195K |
|
341
Kohl's
KSS
$2.1B
| $4.24M | 0.06% |
85,318
+71,849
| +533% | +$3.52M |
|
|
BZUN
342
Baozun
BZUN
$164M
| $4.23M | 0.06% |
99,000
-285,000
| -74% | -$13.5M |
|
343
ONE Gas
OGS
$5.02B
| $4.18M | 0.06% |
43,539
+15,164
| +53% | +$1.38M |
|
344
Phillips 66
PSX
$83.3B
| $4.16M | 0.06% |
40,640
-8,724
| -18% | -$874K |
|
345
Ross Stores
ROST
$78.1B
| $4.14M | 0.05% |
37,696
-14,856
| -28% | -$1.57M |
|
346
Genuine Parts
GPC
$17.6B
| $4.13M | 0.05% |
17,758
+4,386
| +33% | +$421K |
|
347
Equity Residential
EQR
$25.2B
| $4.13M | 0.05% |
47,861
+795
| +2% | +$65K |
|
|
TWTR
348
DELISTED
Twitter, Inc.
TWTR
| $4.12M | 0.05% |
99,912
+7,702
| +8% | +$315K |
|
349
Jefferies Financial Group
JEF
$13B
| $4.09M | 0.05% |
232,711
+109,533
| +89% | +$1.95M |
|
350
Marathon Petroleum
MPC
$91.2B
| $4.09M | 0.05% |
67,360
-3,711
| -5% | -$196K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2019 Portfolio in Review
As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.
- Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
- Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
- Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
- Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
- Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
- Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
- Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.
Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.